Sickle cell V Cystic fibrosis

Sickle-cell disease – a common life-shortening genetic disease -  funding for research, drug development, and patient advocacy $66 million in America

Cystic fibrosis, another condition life-shortening condition - funding for research, drug development, and patient advocacy - $254 million— nearly four times the $66 million spent on sickle cell, even though the latter affects three times as many people.

The National Institutes of Health spends nearly four times as much per patient on cystic fibrosis research as it does on sickle cell. From 2009 to 2011, researchers published twice as many papers on cystic fibrosis as they did on sickle cell.

One disease inflicts mostly people of color. The other mostly white people.

You choose which is which